Cytomegalovirus (CMV) NAAT, Urine and Plasma - Provincial
Discipline
Microbiology
Overview
Description
- CMV is a ubiquitous virus and most people with this infection have no symptoms. Direct detection (+/- quantification) of CMV is performed by nucleic acid amplification testing (NAAT).
Ordering recommendations
- Prospective transplant donors, and prospective or recent transplant recipients
- Immunocompromised individuals with fever, hepatitis, or colitis
- Pregnant women or neonates in the investigation of suspected congenital infection
Specimen Information
Specimen types accepted
- Transplant donors and recipients: Plasma (Viral Load)
- Other immunocompromised: Plasma (Viral Load)
- Pregnant women or neonates: Urine (random)
Specimen collection container
- Plasma: Lavender (EDTA)
Collection procedure
- See Specimen Collection Guide, Random Urine
- Plasma must be separated from whole blood within 24 hours of collection Store plasma at 4°C and ship on ice pack within 48 hours
- Greater than 48 hours, store plasma at -20oC and ship frozen on dry ice
Required volume
- Plasma: Optimum volume is 4 mL; minimum volume is 1 mL
- Urine: optimum volume is 20 mL; minimum volume is 10 mL.
Transport and stability
- Urine: store and transport refrigerated (4°C)
Performance
Methodology
RRPL |
|
RUH |
|
Days/times performed
- All transplant donor/recipient testing and all quantitative CMV viral load testing is performed at the Royal University Hospital Microbiology Laboratory in Saskatoon
- All neonatal testing for the diagnosis of congenital CMV is performed at the Roy Romanow Provincial Laboratory in Regina
- Qualitative diagnostic testing for other indications is performed both in Saskatoon and Regina
Maximum laboratory time
- CMV Quantitative Assay is run every Thursday at RUH
- Qualitative Assay - Time to results 24 – 72 hours after receipt of specimen in laboratory
- Positive CMV NAAT testing in neonates <21 days is a critical result and will be communicated by phone
Specimen retention time
RRPL |
|
RUH |
|
Other information
Patient History
- RRPL: Infants born in Saskatchewan that submit dried blood spots for routine Newborn Screening will be screened for congenital CMV. Individuals with positive screening results require confirmatory testing using CMV NAAT
Last Updated: May 26, 2025